Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD

NCT00485459 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Atomoxetine Hydrochloride
DRUG: Placebo

Sponsor

Eli Lilly and Company